ArticleTurkish journal of anaesthesiology and reanimation2026
Evaluating a Novel Regional Technique: Serratus Posterior Superior Intercostal Plane Block Reduces Opioid Consumption and Pain Scores after Breast-conserving Surgery: A Randomized Controlled Trial.
Article in Turkish journal of anaesthesiology and reanimation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Serratus posterior superior intercostal plane block (SPSIPB) provides thoracic analgesia. Our objective was to assess the analgesic effectiveness of SPSIPB in reducing pain scores and opioid consumption in patients undergoing breast-conserving surgery (BCS) with axillary dissection or sentinel lymph node biopsy. Methods: Participants were individuals aged 18-65 years with American Society of Anesthesiologists physical status I-II who were scheduled for elective BCS under general anaesthesia. Participants were randomly assigned to Group SPSIPB (n = 30) or Group Control (n = 30); the control group received local infiltration anaesthesia. A total of 30 milliliters of 0.25% bupivacaine was during the SPSIPB procedure. The primary outcome of the study was the numerical rating scale (NRS) score at 1 hour postoperatively. Secondary outcomes included 24-hour opioid consumption, need for rescue analgesia, and adverse effects. Results: During the first 24 hours after surgery, the median static and dynamic NRS scores were lower in the SPSIPB group than in the control group ( Conclusion: Opioid consumption and pain scores in the SPSIPB group were significantly lower compared with those in the control group. SPSIPB provides effective analgesia and reduces opioid requirements, offering a valuable opioid-sparing alternative for anaesthesia in breast surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.